Genentech: Home

News & Features

		New Transplant Indication On August 10, 2010, Genentech announced the approval by the U.S. Food and Drug Administration (FDA) of a new indication for one of its medicines for adult kidney transplant patients at high risk for cytomegalovirus (CMV) disease.



		Strike Out Cancer This baseball season, Genentech is participating in the seventh annual Strike Out Cancer program in partnership with the San Francisco Giants and The Wellness Community.

SCIENTIFIC LEADERSHIP >> Genentech's scientists are some of the most prolific in the industry and in their fields.



DEVELOPMENT PIPELINE >> Genentech's pipeline continues to grow, with multiple promising projects in development.

Genentech is committed to making sure price is not a barrier to access for patients.

Genentech's Postdoctoral Program offers promising fellows an opportunity to do cutting-edge research at the forefront of medical science.

View the latest global media releases from the Roche Group on Roche.com.